10-Q · May 15, 2026
DSS, Inc. reported a 13% decline in total revenue for Q1 2026, generating approximately $4.33M, down from $4.95M in Q1 2025. Operating losses increased significantly to $5.49M from $3.73M in the previous year. The…
Earnings analysis · 10-Q
DSS earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
DSS reported a weak second quarter, with revenue down 32% year over year to $3,604,000, negative gross and operating margins, and diluted EPS of negative $0.48. All four operating segments contracted, while six-month…
Read full summary
DSS reported a weak second quarter, with revenue down 32% year over year to $3,604,000, negative gross and operating margins, and diluted EPS of negative $0.48. All four operating segments contracted, while six-month operating cash flow was negative $1,985,000 and free cash flow was approximately negative $2,199,000. Liquidity is the principal concern: cash was $4,068,000 against approximately $39,900,000 of negative working capital, and management stated that substantial doubt remains regarding the company’s ability to continue as a going concern. The filing reports no material changes to the risk factors from the most recent Form 10-K, but unresolved control weaknesses, defaulted debt, and reliance on related-party financing remain significant negatives.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-0.48
- Gross margin
- -25.4%
- Operating margin
- -105.0%
What stood out
-
Revenue Declined 32% Year Over Year
Second-quarter revenue was $3,604,000, down 32% from $5,285,000 in the prior-year quarter and approximately 10% below $4,000,000 in Q1 2026. Management attributed the year-over-year decline to weaker existing-customer orders and delayed customer onboarding.
-
Margins Remained Deeply Negative
Gross margin was negative 25.4%, compared with negative 4.7% in Q1 2026 and approximately 100.0% in the prior-year comparable quarter. Operating margin was negative 105.0%, versus negative 126.7% in Q1 2026 and negative 64.8% in Q2 2025.
-
EPS Improved Sequentially, Worsened YoY
Diluted EPS was negative $0.48, compared with negative $0.60 in Q1 2026 but negative $0.24 in Q2 2025. Net loss attributable to DSS common stockholders was $4,789,000 versus $2,152,000 in the prior-year quarter.
-
All Operating Segments Contracted
Product Packaging revenue was $3,274,000, down 24% year over year, while Securities revenue was $321,000, down 67%. Commercial Lending revenue declined to $6,000 from $9,000, and Biotechnology revenue declined to $3,000 from $7,000.
-
Operating Cash Flow Turned Negative
Six-month operating cash flow was negative $1,985,000 versus positive $454,000 in the prior-year period. Capital expenditures were $214,000, producing six-month free cash flow of approximately negative $2,199,000.
-
Delayed Orders Create Potential Backlog
Management stated that new Product Packaging customer onboarding was pushed to the third and fourth quarters of 2026. It also plans to shift Commercial Lending toward inventory and equipment loans and specialized broker-dealer lending.
What to watch
-
Substantial Going-Concern Doubt
The filing states that substantial doubt remains about going-concern status: cash was $4,068,000, marketable securities were $2,809,000, and negative working capital was approximately $39,900,000. Management acknowledged that asset sales, additional financing, and expense reductions may not be achieved.
-
Defaulted Real Estate Debt
The LifeCare Agreement was in default and past due, with approximately $38,504,000 of outstanding principal and interest at June 30, 2026, including $8,317,000 of accrued interest. Total current liabilities were $49,242,000 versus current assets of $9,368,000.
-
Persistent Operating Losses
Six-month net loss increased to $11,262,000 from $7,902,000, while operating loss increased to $9,274,000 from $7,151,000. The deterioration occurred despite total costs and expenses declining only 1% to $17,208,000.
-
Material Control Weaknesses Persist
The company’s disclosure controls and procedures remained ineffective as of June 30, 2026 because material weaknesses reported in the 2025 Form 10-K remained unresolved. Management said remediation steps were still being implemented and tested.
-
Loan Portfolio Credit Deterioration
Commercial Lending revenue fell 63% year over year to $6,000 because several loans moved to non-accrual status. The company maintained a loan-loss reserve of approximately $7,478,000, including reserves against multiple defaulted loans.
-
Related-Party Financing and Dilution
The company issued related-party convertible notes with principal amounts of $2,450,000 and $1,000,000 during 2026, alongside warrants for 16,554,055 and 17,777,776 shares, respectively. Common shares outstanding increased to 10,042,518 from 9,092,518 at December 31, 2025.
Management's outlook
No quantitative revenue or EPS guidance was provided. Management expects several new Product Packaging customers to onboard in the third and fourth quarters of 2026, is pursuing potential asset sales and additional financing, and plans continued reductions in operating expenses and cash burn.
Earlier filings 4
10-K · March 31, 2026
DSS describes a multi-pronged strategy to optimize operations, streamline its portfolio and scale four core businesses (Product Packaging, Biotechnology, Commercial Lending, Securities & Investment Management) with a…
10-Q · August 14, 2025
DSS reported Q2 revenue of $5,285,000, up $1,074,000 (+25.5%) versus Q2 2024 and up modestly versus Q1 2025. Loss per share narrowed to $(0.24) from $(0.66) a year earlier, and operating loss improved to $(3,425,000)…
10-Q · May 15, 2025
Revenue rose to $4,954,000 for the quarter (up $1,083,000 or +28.0% vs $3,871,000 a year ago) driven by printed products and higher rental income, but the company remained unprofitable with a net loss of $5,296,000 and…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.